Biocon Biologics receives positive CHMP opinions for denosumab biosimilars Vevzuo and Denosumab BBL
European Medicines Agency’s CHMP recommends approval of Biocon Biologics' denosumab biosimilars for bone health indications
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Sun Pharma must immediately declare a voluntary recall of Levipil 500
Dr Avi Chaudhuri, expert on anti-counterfeiting has further analysed the recent counterfeiting case of Sun Pharma’s Levipil 500.…
ENTOD Pharmaceuticals receives CDSCO approval for paediatric myopia treatment
The formulation, approved following Phase 3 trials in India, becomes the first globally authorised treatment strength for slowing…
Building a pharma-ready logistics network: The need for compliance, speed, and scalability
In the article, Nitesh Agarwal, President of CJ Darcl Logistics, outlines the critical infrastructure, regulatory, and…
Morepen Laboratories expands its domestic portfolio
The company strengthens its finished dosages business with new products across cardiology, hepatology, nutrition, and…
Cadila Pharmaceuticals marks three years of ThRabis, a three-dose rabies vaccine
ThRabis rollout sees increased vaccine compliance and reduced treatment burden across multiple regions
Avery Dennison opens first RFID inlay and label production facility in India
Pune facility marks company's expansion under 'Make in India' initiative, enabling local RFID manufacturing and supply chain…
Lupin receives US FDA approval for generic Tolvaptan Tablets
Company secures 180-day marketing exclusivity as first-to-file applicant for bioequivalent to Jynarque
Oxford Nanopore and BRIC Institutes sign Letters of Intent to establish two Centres of Excellence in…
Collaborations with BRIC-CDFD and BRIC-NIBMG to support rare disease, cancer, and infectious disease research using Oxford…
India advances indigenous HPV screening kits for cervical cancer through DBT-BIRAC partnership
Department of Biotechnology-led initiative under review; Minister Jitendra Singh highlights public-private collaboration and…